David C Bloom

David C Bloom

PROFESSOR

Department: MD-MOLECULAR GENTCS / MICROBIO
Business Phone: (352) 273-9524
Business Email: dbloom@ufl.edu

Publications

2017 Methods in Molecular Biology
2014 Computational and Structural Biotechnology Journal
2010 Biochimica Et Biophysica Acta-General Subjects

Grants

Aug 2019 ACTIVE
Phenotypic analyses of HSV-1 miRNAs: H1, H6, & H8
NATL INST OF HLTH NIAID · Mentor
Mar 2019 ACTIVE
Molecular Genetics of HSV Reactivation
NATL INST OF HLTH NIAID · Principal Investigator
Nov 2018 ACTIVE
CTCF-mediated HSV-1 gene expression during latency and reactivation
UNIV OF WISCONSIN MADISON · Principal Investigator
Oct 2018 ACTIVE
Analysis of the specific effects of Tranexamic Acid on HSV infection
ANTI PLASMIN TECHNOLOGIES · Principal Investigator
Sep 2016 – Aug 2018
Analysis of human-specific aspects of HSV-1 latency in human iPSC-derived neurons
UNIV OF PITTSBURGH · Principal Investigator
Jun 2016 – May 2018
OR-DRPD-ROF2016: Visualizing viral entry into neurons and the brain: Changing the paradigm
UF DSR OPPORTUNITY FUND ·
Jan 2016 – Dec 2016
Vector-delivered CRISPR/Cas as a cure for HSV-1 induced
EDITAS MEDICINE · Principal Investigator
Sep 2015 – Aug 2016
The Role of the LAT Locus in HSV-1 Infection
STANFORD UNIV · Principal Investigator
Jul 2015 – Jun 2018
Function of histone chaperones in HSV-1 chromatin sturct
NATL INST OF HLTH NIAID · Project Manager
Jun 2015 – Jun 2016
Effect of spaceflight on Herpesvirus genome stability an
NASA · Principal Investigator
Aug 2014 – Apr 2017
Cytotoxic lymphocytes and HSV-1 corneal lesions
UNIV OF PITTSBURGH · Principal Investigator
Aug 2014 ACTIVE
Basic Microbiology and Infectious Disease
NATL INST OF HLTH NIAID · Principal Investigator
Jan 2014 – Jan 2017
Determination of Roles of Microgravity and Ionizing Radi
NASA STENNIS SPACE FLIGHT CTR · Principal Investigator
Jul 2013 ACTIVE
Evaluation of the suitability of SafeSwitch-controlled HSV as anti-herpetic"vaccines" or as immunization platform
HSF PHARMACEUTICALS SA · Principal Investigator
Jan 2012 – Dec 2017
Regulation of lytic and latent infection by HSV-1 encode
NATL INST OF HLTH NIAID · Principal Investigator
Jul 2010 ACTIVE
HSV-2 Research Program – UFF Transfer Account
UF FOU · Principal Investigator
Jul 2010 ACTIVE
HSV-1 Research Program – UFF Transfer Account
UF FOU · Principal Investigator

Patents

Issued May 1993
Biological System for Constructing and Testing Viral Vaccines Culture Of Poxvirus and Plasmids
#5,212,057
Issued February 2008
Herpesvirus Ribozymes and Vectors
#7,335,763
Issued November 2010
Herpesvirus Ribozymes and Vectors (CIP)
#7,838,659
Issued May 2015
Insulated Herpesvirus-derived Gene Expression Cassette for Sustained and Regulatable Gene Expression
#9,023,617
Published September 2016
Method for the Treatment of Latent Infection with HSV-1 or HSV-2
#US2017/0020994
Issued May 2017
Insulated Herpesvirus-derived Gene Expression Cassette for Sustained and Regulatable Gene Expression (DIV 11434)
#9,636,354

Contact Details

Phones:
Business:
(352) 273-9524
Emails:
Business:
dbloom@ufl.edu